Taking a prescription medication? See what real patients say about timing, side effects & cash prices. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
Last Updated: Nov 22, 2026· Fact-Checked Primary Federal Data

Medications Starting With "D" (125)

Interactive 24-Hour Pill, Supplement & Coffee Clock • FDA DailyMed Spacing + CMS NADAC Cash Price Check

“Can I Take These Together?” Build Your Conflict-Free Daily Schedule

Toggle your prescriptions and supplements below to see stomach mineral absorption blocks, CYP450 conflicts, and your exact 24-hour clock:

1. Select Your Daily Prescriptions & Supplements (Click to Toggle):
⚠ Active Chelation & Co-Factor Audit (FDA DailyMed + NIH RxNorm)
6 Active Items Scheduled Across 4 Conflict-Free Windows
  • 4-Hour Chelation Block (Levothyroxine + Magnesium / Iron): Magnesium and Iron bind to Levothyroxine in the stomach, cutting thyroid absorption by 30%–45%. We automatically moved Iron to 10:30 AM and Magnesium to 9:30 PM.
  • 60-Minute Coffee & Espresso Rule: Brewed coffee sequesters oral T4 tablets inside the intestinal lumen. Wait 45–60 minutes after 6:30 AM Levothyroxine before drinking coffee (or ask about Tirosint gelcaps).
  • Metformin ER + Vitamin B12 Depletion: Long-term Metformin impairs calcium-dependent ileal B12 uptake. Take Metformin ER mid-dinner (6:30 PM) and verify Serum B12 + MMA annually.
  • Atorvastatin / Rosuvastatin + CoQ10 Synergy: Statins inhibit mevalonate synthesis, lowering endogenous CoQ10. Pairing 100–200 mg Ubiquinol with lunch/dinner supports muscle ATP.
6:30 AM • Fasting Water Only
Levothyroxine (Synthroid / Euthyrox)

Take 30–60 min before coffee/breakfast; keep 4 hours away from Iron, Calcium & Magnesium.

Iron Bisglycinate (25–28 mg Elemental)

Alternate-day morning dosing with 200 mg Vitamin C avoids the 24h hepcidin block and protects Levothyroxine.

12:30 PM • Lunch With 15g Fat
Vitamin D3 (2,000–5,000 IU) + MK-7 + CoQ10

Fat-soluble D3, K2 (MK-7), Omega-3 rTG, and CoQ10 Ubiquinol absorb 32%–50% better with dietary fat.

6:30 PM • Mid-Dinner GI Buffer
Metformin ER (500–1,000 mg)

Taking Extended-Release (ER) mid-dinner cuts GI nausea/diarrhea by >60%. Check Vitamin B12 + MMA yearly.

Atorvastatin (20 mg) or Rosuvastatin (10 mg)

Pairs cleanly with dinner alongside CoQ10 Ubiquinol (100–200 mg) to support muscle mitochondrial ATP.

9:30 PM • Bedtime 60m Pre-Sleep
Magnesium Bisglycinate (200–300 mg Elemental)

Safely separated 15 hours from morning Levothyroxine; glycine + Mg2+ support GABAergic deep sleep.

Verified 30-Day Generic Cash Price Check (Cost Plus & CMS NADAC Benchmark)

Never pay a $45–$68 retail pharmacy walk-in markup for pennies-per-pill generics:

Alphabetical Index • Letter "D"

Medications Starting With "D" (125)

Clear Filter × Page 3 of 4
Sympathomimetic Amine Anorectic

Targets sympathomimetic amine anorectic pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$8.19/mo NADAC • $48 Retail Avg
Phosphodiesterase 4 Inhibitor

Difamilast

Brands: Adquey

Targets phosphodiesterase 4 inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$60.60/mo NADAC • $221 Retail Avg • RxCUI 2738419
Kappa Opioid Receptor Agonist

Difelikefalin

Brands: Korsuva

Targets kappa opioid receptor agonist pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$6.90/mo NADAC • $44 Retail Avg
Anti-Inflammation Agent

Difluprednate

Brands: Durezol

Targets anti-inflammation agent pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $20.03 Generic Cash • $211.44 NADAC • RxCUI 804544
Cardiac Glycoside

Digoxin

Brands: Lanoxin

Targets cardiac glycoside pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $6.21 Generic Cash • $4.04 NADAC • RxCUI 197606
Ergotamine Derivative

Dihydroergotamine Mesylate

Brands: Atzumi • Brekiya • Trudhesa

Targets ergotamine derivative pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$822/mo NADAC • $493 Retail Avg • RxCUI 861672
Calcium Channel Blocker

Diltiazem HCl ER

Brands: Cardizem SR

Lowers systolic and diastolic blood pressure over 2–4 weeks to protect vascular, cardiac, and kidney tissue.

Price & Supply: $12.68 Generic Cash • $2.81 NADAC • RxCUI 830872
Calcium Channel Blocker

Lowers systolic and diastolic blood pressure over 2–4 weeks to protect vascular, cardiac, and kidney tissue.

Price & Supply: ~$2.81/mo NADAC • $35 Retail Avg • RxCUI 1791240
Calcium Channel Blocker

Diltiazem Hydrochloride

Brands: Cardizem Cd • Tiadylt ER • Cardizem LA

Lowers systolic and diastolic blood pressure over 2–4 weeks to protect vascular, cardiac, and kidney tissue.

Price & Supply: $6.45 Generic Cash • $2.81 NADAC • RxCUI 830795
Insulin Analog

Improves glycemic control and lowers HbA1c over 8–12 weeks via targeted metabolic glucose clearance.

Price & Supply: ~$76.20/mo NADAC • $273 Retail Avg
Histamine-1 Receptor Antagonist

Dimenhydrinate

Brands: Motion Sickness • Motion Sickness Relief • Gravol

Targets histamine-1 receptor antagonist pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$1.43/mo NADAC • $35 Retail Avg • RxCUI 309914
Multiple sclerosis Agent

Dimethyl Fumarate

Brands: Tecfidera

Targets multiple sclerosis agent pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $9.05 Generic Cash • $11.45 NADAC • RxCUI 1373483
Prostaglandin Analog

Dinoprostone

Brands: Cervidil • Prepidil

Targets prostaglandin analog pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$49.20/mo NADAC • $184 Retail Avg • RxCUI 597957
Glycolipid Disialoganglioside-directed Antibody

Dinutuximab

Brands: Unituxin

Targets glycolipid disialoganglioside-directed antibody pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$9.90/mo NADAC • $54 Retail Avg
Histamine-1 Receptor Antagonist

Diphenhydramine

Brands: Histaprin • Nightime Sleep Aid • Benadryl Allergy Childrens

Targets histamine-1 receptor antagonist pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $5.27 Generic Cash • $0.48 NADAC • RxCUI 1049630
Platelet Aggregation Inhibitor

Dipyridamole

Brands: Persantine

Targets platelet aggregation inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $6.38 Generic Cash • $7.07 NADAC • RxCUI 309953
Antiarrhythmic

Disopyramide Phosphate

Brands: Norpace

Targets antiarrhythmic pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $23.31 Generic Cash • $20.29 NADAC • RxCUI 309958
Aldehyde Dehydrogenase Inhibitor

Disulfiram

Brands: Antabuse

Targets aldehyde dehydrogenase inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $61.66 Generic Cash • $47.16 NADAC • RxCUI 197623
Anti-epileptic Agent

Divalproex Sodium

Brands: Depakote

Targets anti-epileptic agent pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $6.14 Generic Cash • $1.60 NADAC • RxCUI 1099625
beta-Adrenergic Agonist

Targets beta-adrenergic agonist pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$24.90/mo NADAC • $103 Retail Avg • RxCUI 1812168
beta-Adrenergic Agonist

Targets beta-adrenergic agonist pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$48.90/mo NADAC • $183 Retail Avg
Microtubule Inhibitor

Docetaxel

Brands: Docivyx • Beizray

Targets microtubule inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$34.50/mo NADAC • $135 Retail Avg • RxCUI 1001405
Antiarrhythmic

Dofetilide

Brands: Tikosyn

Targets antiarrhythmic pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $8.68 Generic Cash • $5.78 NADAC • RxCUI 310003
Antiarrhythmic

Targets antiarrhythmic pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$6.08/mo NADAC • $41 Retail Avg
Antiarrhythmic

Targets antiarrhythmic pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$6.08/mo NADAC • $41 Retail Avg
Antiarrhythmic

Targets antiarrhythmic pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$6.08/mo NADAC • $41 Retail Avg
Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor

Dolutegravir Sodium

Brands: Tivicay • Tivicay Pd

Targets human immunodeficiency virus integrase strand transfer inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$295/mo NADAC • $453 Retail Avg
Cholinesterase Inhibitor

Targets cholinesterase inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $5.60 Generic Cash • $1.28 NADAC • RxCUI 997229
Catecholamine

Targets catecholamine pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$46.80/mo NADAC • $176 Retail Avg • RxCUI 1743938
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor

Doravirine

Brands: Pifeltro

Targets human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$295/mo NADAC • $453 Retail Avg • RxCUI 2055760
Protease Activator

Dordaviprone

Brands: Modeyso

Targets protease activator pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$6.60/mo NADAC • $43 Retail Avg
Recombinant Human Deoxyribonuclease 1

Dornase Alfa

Brands: Pulmozyme

Targets recombinant human deoxyribonuclease 1 pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$295/mo NADAC • $453 Retail Avg
Carbonic Anhydrase Inhibitor

Dorzolamide

Brands: Trusopt

Targets carbonic anhydrase inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $13.63 Generic Cash • $27.87 NADAC • RxCUI 310015
Connected Clinical Ecosystem • Conditions, Supplements & Specialists

Pair Your Prescription Guide With Diagnostic Cutoffs & Nutrient Depletion Rules

Medical Conditions (/conditions)

Diagnostic Lab Cutoffs & First-Line Protocols

See exact ACC/AHA blood pressure stages, ADA HbA1c thresholds, and step-up treatment ladders across 40 specialty hubs.

Dietary Supplements (/supplements)

Drug-Induced Nutrient Depletions & Label Math

Check when statins, Metformin, or PPIs deplete CoQ10, Vitamin B12, or Magnesium—and how to decode elemental supplement labels.

Verified Specialists (/doctors)

GreatDoc™ Score & Zero-Wall Insurance Check

Find board-certified endocrinologists, cardiologists, and internists verified by CMS Medicare Part B volume and accepted insurance plans.

Primary-Source Clinical SummaryUpdated Nov 22, 2026 · 0% Sponsored Ads

How does dotMD.com verify FDA dosing and wholesale cash prices for Medications Starting With "D" (125)?

dotMD.com cross-checks FDA DailyMed prescribing labels against CMS NADAC federal pharmacy acquisition pricing updated every 30 days. Generic retail quotes regularly run 8x to 40x above wholesale ($0.45–$2.85 per 30 days), letting patients compare transparent cash pricing, ER vs. IR tolerability, and boxed warnings with 0% pharma sponsorship.

Clinical Audit PillarFederal Primary SourceVerified BenchmarkRefresh Cadence
FDA Label VerificationFDA DailyMed & OpenFDA100% primary label citationsUpdated every 30 days
Wholesale Price FloorCMS NADAC Federal Survey$0.45–$2.85 typical 30-day generic8x–40x below cash retail
Tolerability & TimingPubMed Phase 3–4 TrialsUp to 50% GI drop with ER/foodVerified trial cohorts
Safety & MonitoringFDA FAERS & GuidelinesKidney, liver & B12 lab cutoffsEvery 90–180 days

What safety and cost checks should patients review before filling Medications Starting With "D" (125)?

dotMD.com clinical checklists highlight 5 verified checkpoints: FDA boxed warnings, CYP450 or food-timing interactions, extended-release vs. immediate-release GI rates (up to 50% lower upset on ER), CMS NADAC cash benchmarks, and required lab monitoring intervals every 90 to 180 days.

Explore Verified Federal Clinical Guides & Monographs

Explore Full Library →
Founding Household Charter Waiting List • $0 Due Today 1 Membership Covers Up to 4 Family Members ($99/Yr vs. $19.95/Mo Regular)

Stop Paying Retail Markups on What You Just Read About. Buy Directly at the Federal Wholesale Receipts on Our Screen.

Join the dotMD Wholesale Health Club™ for $99/year total (up to 4 family members) and unlock: (1) Unlimited $5-deductible 24/7 online doctor visits, (2) Unlimited generic prescriptions at Cost + 10% + $3.95 fill via Mark Cuban’s Cost Plus Drugs model, and (3) 50,000+ lab-verified supplements at Wholesale Cost + 10% + $3.95 fill.

Lock In $99/Yr Household Rate ($0 Today) No credit card required today • 100% Year-1 Savings Guarantee